In Brief This Week: Beckman Coulter; Lab21; Pacific Biometrics; Caprion Proteomics, Thallion Pharmaceuticals; FASEB | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter this week set a preliminary 2010 guidance for adjusted earnings per share of between $4.40 and $4.55. According to Thomas Weisel Partners analyst Peter Lawson, the guidance is below analysts' consensus estimate of $4.56.

"While initial 2010 guidance was below consensus, we believe management is maintaining a conservative outlook on the Olympus synergies and economic conditions," he wrote in a research note published Thursday evening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.